concept

NEUROTOXICITY

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROTOXICITY: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

1236Connections

1Hypotheses

1Analyses

50Outgoing

50Incoming

Summary

NEUROTOXICITY is a concept in neurodegeneration research. Key relationships include: activates, therapeutic target, associated with. Associated with ALS, Aging, Als. Connected to 676 entities in the SciDEX knowledge graph.

View on Wiki →

💡 Concept Info

Name	NEUROTOXICITY
Key Genes/Proteins	NEUROINFLAMMATION, NEURODEGENERATION, MICROGLIA, OXIDATIVE STRESS, ALZHEIMER'S DISEASE, ALZHEIMER
Related Diseases	Inflammation, Als, Neuroinflammation, Neurodegeneration, Alzheimer
Related Pathways	Autophagy, Oxidative Stress, Apoptosis
Linked Hypotheses	1 hypotheses

Wiki Pages (20)

Knowledge base pages for this entity

cbs-psp-daily-action-plan

therapeutic · 30834 words

→

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

therapeutic · 15794 words

→

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

therapeutic · 15567 words

→

Corticobasal Syndrome (CBS)

disease · 11374 words

→

Parkinson's Disease

disease · 8807 words

→

Pathway Diagram

graph TD
    NEUROTOXICITY["NEUROTOXICITY"]
    NEUROTOXICITY -->|"activates"| Inflammation["Inflammation"]
    NEUROTOXICITY -->|"activates"| Als["Als"]
    NEUROTOXICITY -->|"activates"| Neuroinflammation["Neuroinflammation"]
    NEUROTOXICITY -->|"inhibits"| Amyotrophic_Lateral_Sclerosis["Amyotrophic Lateral Sclerosis"]
    NEUROTOXICITY -->|"inhibits"| Dementia["Dementia"]
    NEUROTOXICITY -->|"activates"| Parkinson["Parkinson"]
    NEUROTOXICITY -->|"activates"| Ms["Ms"]
    NEUROTOXICITY -->|"activates"| Neurodegeneration["Neurodegeneration"]
    SNCA["SNCA"] -->|"causes"| NEUROTOXICITY
    complement["complement"] -->|"activates"| NEUROTOXICITY
    PI3K_AKT["PI3K-AKT"] -->|"regulates"| NEUROTOXICITY
    catalase_mRNA["catalase mRNA"] -.protects against.-> NEUROTOXICITY
    impaired_autophagic_flux["impaired autophagic flux"] -->|"causes"| NEUROTOXICITY
    P62["P62"] -->|"inhibits"| NEUROTOXICITY
    DDX3X["DDX3X"] -->|"activates"| NEUROTOXICITY
    AMYOTROPHIC_LATERAL_SCLEROSIS["AMYOTROPHIC LATERAL SCLEROSIS"] -->|"inhibits"| NEUROTOXICITY
    PARKINSON_S_DISEASE["PARKINSON'S DISEASE"] -->|"activates"| NEUROTOXICITY
    NEURODEGENERATION["NEURODEGENERATION"] -->|"activates"| NEUROTOXICITY

Outgoing (799)

Target	Relation	Type	Str
NEUROINFLAMMATION	activates	gene	1.00
Inflammation	activates	disease	1.00
Als	activates	disease	1.00
Neuroinflammation	activates	disease	1.00
Neurodegeneration	activates	disease	1.00
Autophagy	activates	pathway	1.00
Alzheimer	activates	disease	1.00
Neurodegeneration	associated_with	disease	1.00
Oxidative Stress	activates	pathway	1.00
Apoptosis	activates	pathway	1.00
NEURODEGENERATION	activates	gene	1.00
MICROGLIA	activates	gene	1.00
OXIDATIVE STRESS	activates	gene	1.00
ALZHEIMER'S DISEASE	activates	gene	1.00
ALZHEIMER	activates	gene	1.00
Als	therapeutic_target	disease	1.00
APOPTOSIS	activates	gene	1.00
NEURODEGENERATIVE DISEASES	activates	gene	1.00
PARKINSON'S DISEASE	therapeutic_target	gene	1.00
PARKINSON	therapeutic_target	gene	1.00
Parkinson	therapeutic_target	disease	1.00
Aging	therapeutic_target	disease	1.00
Inflammation	therapeutic_target	disease	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
ALZHEIMER	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	therapeutic_target	gene	1.00
Neurodegeneration	therapeutic_target	disease	1.00
Alzheimer	therapeutic_target	disease	1.00
CYTOKINES	activates	gene	1.00
AUTOPHAGY	activates	gene	1.00
Nf-Κb	activates	pathway	1.00
NEURODEGENERATION	associated_with	gene	1.00
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	1.00
Neuroinflammation	therapeutic_target	disease	0.95
AMPK	activates	gene	0.90
TNF-Α	activates	gene	0.90
Ferroptosis	activates	pathway	0.90
Mtor	activates	pathway	0.90
TAU	activates	gene	0.90
NF-ΚB	activates	gene	0.90
MTOR	activates	gene	0.90
NEURON	activates	gene	0.90
AMYLOID	activates	gene	0.90
PARKINSON'S DISEASE	activates	gene	0.90
NEUROINFLAMMATION	therapeutic_target	gene	0.90
OXIDATIVE STRESS	therapeutic_target	gene	0.90
Oxidative Stress	therapeutic_target	pathway	0.90
NRF2	activates	gene	0.90
Parkinson	activates	disease	0.85
Aging	activates	disease	0.85

Incoming (437)

Source	Relation	Type	Str
ROS	activates	gene	1.00
APOPTOSIS	activates	gene	1.00
SNCA	causes	gene	0.90
AUTOPHAGY	activates	gene	0.90
MITOPHAGY	activates	gene	0.80
APOPTOSIS	therapeutic_target	gene	0.80
NEURODEGENERATION	activates	gene	0.70
INFLAMMATION	activates	gene	0.70
TAU	activates	gene	0.70
AUTOPHAGY	regulates	gene	0.70
APOPTOSIS	regulates	gene	0.70
MYELIN	activates	gene	0.70
NLRP3	activates	gene	0.70
KEAP1	activates	gene	0.70
GSDMD	activates	gene	0.70
ERK	activates	gene	0.70
NEURODEGENERATION	causes	gene	0.70
P62	inhibits	gene	0.60
RAN	associated_with	gene	0.60
DDX3X	activates	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	inhibits	gene	0.60
PARKINSON'S DISEASE	activates	gene	0.60
ULK1	activates	gene	0.60
MITOCHONDRIAL DYSFUNCTION	activates	gene	0.60
PARKINSON'S DISEASE	interacts_with	gene	0.60
NEURODEGENERATIVE DISEASES	interacts_with	gene	0.60
P62	interacts_with	gene	0.60
MITOCHONDRIAL DYSFUNCTION	interacts_with	gene	0.60
GABARAP	interacts_with	gene	0.60
TNF	activates	gene	0.60
FERROPTOSIS	activates	gene	0.60
DIABETES MELLITUS	activates	gene	0.60
MICROGLIA	activates	gene	0.60
COP1	activates	gene	0.60
UBIQUITIN	activates	gene	0.60
ALZHEIMER'S DISEASE	activates	gene	0.60
COMPLEMENT	inhibits	gene	0.60
PRO-INFLAMMATORY GENES	activates	gene	0.60
SKA2	regulates	gene	0.60
ALZHEIMER'S DISEASE	regulates	gene	0.60
CYTOKINES	activates	gene	0.60
PROINFLAMMATORY CYTOKINES	activates	gene	0.60
MICROGLIA	regulates	gene	0.60
MOTOR NEURONS	expressed_in	gene	0.60
SOD1	regulates	gene	0.60
TNF	expressed_in	gene	0.60
AMYOTROPHIC LATERAL SCLEROSIS	expressed_in	gene	0.60
SNAP23	activates	gene	0.60
NEURODEGENERATIVE DISEASES	regulates	gene	0.60
APP/PS1	activates	gene	0.60

Targeting Hypotheses (1)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
DLK MAPK Pathway Inhibition to Block Tau-Induced Neurotoxici	0.609	neurodegeneration	Should microtubule-stabilizing drugs be

Mentioning Analyses (1)

Scientific analyses that reference this entity

Systemic immune profiling and peripheral immune contributions to neurodegenerati

neurodegeneration | 2026-04-04 | 0 hypotheses

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

NEUROTOXICITY

Understanding Entity Pages

Summary

Wiki Pages (20)

cbs-psp-daily-action-plan

Personalized Treatment Plan — Atypical Parkinsonism (CBS/PSP)

AAV Gene Therapy for Neurodevelopmental Epilepsy — Competitive Landscape & Delivery Alternatives

Corticobasal Syndrome (CBS)

Parkinson's Disease

Sleep and Circadian Dysfunction in Alzheimer's Disease

Parthanatos in Neurodegeneration

Section 148: Advanced Nutritional Biochemistry in CBS/PSP

Myoclonus and Cortical Hyperexcitability in Corticobasal Syndrome

nimodipine-als

Section 162: Advanced Antioxidant and Redox Therapy in CBS/PSP

neuroinflammation

NRF2 Oxidative Stress Pathway

Microglial Cells — Cell Type Hierarchy

Astrocyte Reactivity Mechanism

rasagiline

Tau Spreading Mechanism

oxidative-stress-comparison

APOC4 — Apolipoprotein C-IV